Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'tranylcypromine 2 pcpa hcl'

Search results for: 'tranylcypromine 2 pcpa hcl'

Items 71-80 of 118

Page
per page
  1. PRT062607 Hydrochloride
    A3736 PRT062607 Hydrochloride
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and selective
      ≥21.5 mg/mL
  2. BMS-794833
    B1438 BMS-794833
    Target: MET|Flk-1
    Summary: Met/VEGFR-2 inhibitor,potent and ATP-competitive
      ≥23.45 mg/mL
  3. AZD4547
    A8350 AZD4547
    Target: FGFR
    Summary: FGFR inhibitor
      ≥23.2 mg/mL
  4. Telatinib (BAY 57-9352)
    A8550 Telatinib (BAY 57-9352)
    Target: VEGFR|PDGFR|c-Kit
    Summary: VEGFR-2/-3,PDGFR-β and c-Kit inhibitor
      insoluble in H2O; insoluble in EtOH; ≥20.5 mg/mL
  5. Fruquintinib(HMPL-013)
    B5864 Fruquintinib(HMPL-013)
    Target: VEGFR
    Summary: Potent and selective inhibitor of VEGFR 1, 2, 3
      insoluble in H2O; insoluble in EtOH; ≥6.35 mg/mL
  6. PP 3
    B7190 PP 3
    Summary: Negative control for the Src kinase inhibitor PP 2
      Soluble in DMSO
  7. WZ3146
    A8881 WZ3146
    Summary: Mutant EGFR inhibitor, potent and irreversible
      ≥23.25 mg/mL
  8. Lapatinib Ditosylate
    A3967 Lapatinib Ditosylate
    Target: EGFR|ErbB-2
    Summary: EGFR/HER2 inhibitor,potent and selective
      ≥24.3 mg/mL
  9. Lck Inhibitor
    A3539 Lck Inhibitor
    Summary: Lck inhibitor
      Soluble in DMSO
  10. Neratinib (HKI-272)
    A8322 Neratinib (HKI-272)
     1 Citation
    Target: EGFR
    Summary: HER2/EGFR inhibitor,potent and irreversible
      insoluble in H2O; ≥13.93 mg/mL

Items 71-80 of 118

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 4item
  2. Ack1 1 item
  3. Axl 1 item
  4. ALK 4item
  5. Broad Spectrum Protein Kinase Inhibitor 3item
  6. c-FMS 1 item
  7. c-Kit 2item
  8. c-MET 8item
  9. c-RET 3item
  10. CSF-1R 1 item
  11. EGFR 24item
  12. FAK 4item
  13. FGFR 6item
  14. FLT3 4item
  15. HER2 7item
  16. IGF1R 2item
  17. Insulin Receptor 3item
  18. IRAK 1 item
  19. Lck 1 item
  20. LRRK2 4item
  21. PDGFR 9item
  22. PTKs/RTKs 1 item
  23. Pyk2 2item
  24. ROR 1 item
  25. Spleen Tyrosine Kinase (Syk) 2item
  26. Src 5item
  27. Tie-2 2item
  28. Trk 1 item
  29. VEGFR 30item
Specificity
  1. Selective 46item
Reversibility
  1. Reversible 6item
  2. Irreversible 4item
Target
  1. Raf 4item
  2. CSF-1R 1 item
  3. FLT3 4item
  4. Eph Receptors 1 item
  5. VEGFR 24item
  6. PDGFR 7item
  7. c-Kit 5item
  8. RET 2item
  9. Bcr-Abl 2item
  10. FGFR 7item
  11. MET 4item
  12. Src 2item
  13. Trk Receptors 2item
  14. EGFR 11item
  15. FAK 3item
  16. BMP and Other Activin Receptors 1 item
  17. Syk 2item
  18. ErbB 2item
  19. c-MET 2item
  20. PKC 1 item
  21. Pyk2 3item
  22. LRRK2 4item
  23. Insulin and Insulin-like Receptors 1 item
  24. ALK 1 item
  25. PKG 1 item
  26. PKA 1 item
  27. Myosin light chain kinases (MLCKs) 1 item
  28. Tie-2 3item
  29. Flk-1 1 item
  30. KDR 1 item
  31. Fyn kinase 1 item
  32. c-Fms tyrosine kinase 1 item
  33. Lyn kinase 1 item
  34. ErbB-2 1 item
  35. DCLK2 1 item
  36. Flk1 1 item
Reported Experiments
  1. Animal Experiments 58item
  2. Cell Experiments 42item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 12item
  7. Cancer 44item
  8. Cholangiocarcinoma 1 item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 3item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 7item
  14. Glioblastoma 3item
  15. Glioma 2item
  16. Hepatocellular Carcinoma 2item
  17. Liver Cancer 2item
  18. Lung Cancer 3item
  19. Lung Carcinoma 1 item
  20. Lymphoma 1 item
  21. Melanoma 2item
  22. Multiple Myeloma 3item
  23. Non-small Cell Lung Cancer 3item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 7item
  26. Prostate Cancer 3item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 3item
  29. Thyroid Cancer 3item